Product image of Illuccix (Gozetotide) supplied by GNH India

Illuccix

Active Ingredient:
Gozetotide
Origin:
EU

Illuccix (Gozetotide)

Gozetotide, the active ingredient in Illuccix, is a drug presented as an intravenous formulation for infusion use. It is currently under clinical investigation and its therapeutic targets are not publicly disclosed.

GNH India supplies Illuccix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product is manufactured in accordance with EU regulations.

Manufacturer / TM Owner

Telix Innovations

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Illuccix (gozetotide) is being evaluated in early‑stage research for potential applications in rare disease therapeutics, but no approved indications have been announced.
  • No approved indication: No specific therapeutic use has been authorized to date.

How It Works

  • The precise mechanism of action of gozetotide has not been disclosed in publicly available literature. It is believed to interact with cellular pathways involved in disease modulation, but detailed target information remains confidential. Current research suggests it may bind to specific receptors or proteins, influencing signaling cascades relevant to its investigational therapeutic areas.

Side Effects

Adverse event information for Illuccix (gozetotide) has not been fully published.

Common Side Effects

  • No reported common side effects: Data not available.
  • Mild infusion reaction: Possible transient flushing or warmth.
  • Transient laboratory changes: Possible temporary alterations in blood counts.

Serious or Rare Side Effects

  • No reported serious side effects: Data not available.
  • Severe hypersensitivity: Potential for anaphylaxis, though unconfirmed.
  • Organ toxicity: No documented cases, but monitoring is advised.

Precautions & Warnings

Because clinical data are limited, careful monitoring is recommended when Illuccix is administered.

  • Clinical monitoring: Observe patients for any unexpected reactions during and after infusion.
  • Contraindications: Not recommended for patients with known hypersensitivity to the product.
  • Pregnancy considerations: Use only if the potential benefit justifies the potential risk; data are lacking.
  • Breastfeeding: Caution advised; insufficient information on excretion in milk.
  • Renal/hepatic impairment: Adjustments have not been defined; monitor organ function.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Interaction data for gozetotide are limited; clinicians should remain vigilant.

Major Interactions (Avoid)

  • No known major drug interactions have been identified.
  • Concomitant use with potent immunosuppressants: Potential additive immunomodulation, monitor closely.

Moderate Interactions (Monitor Closely)

  • Certain biologics: May alter immune response; assess patient status.
  • CYP450 substrates: Interaction potential is unclear; observe therapeutic levels.
  • Anticoagulants: Monitor coagulation parameters if used together.

Frequently Asked Questions

Illuccix contains the active ingredient gozetotide and is currently being studied in early‑phase clinical trials. No approved therapeutic indication has been announced, and its potential uses remain investigational.

The exact mechanism of gozetotide has not been publicly disclosed. Preliminary research suggests it may bind to specific cellular receptors or proteins, influencing signaling pathways that are relevant to the disease areas under investigation.

Dosing for Illuccix is determined by the prescribing clinician based on the specific study protocol or therapeutic context. No standardized dose is publicly available.

Safety data for gozetotide in pregnancy or lactation are insufficient. It should only be used if the potential benefit outweighs the potential risk, and the decision should be made by a qualified healthcare professional.

To request Illuccix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Because gozetotide’s drug class and detailed pharmacology have not been publicly defined, direct comparisons are limited. Clinicians typically evaluate investigational agents based on available pre‑clinical data, safety signals, and early efficacy trends.

Illuccix should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Follow the manufacturer’s cold‑chain guidelines to maintain product integrity.

Illuccix is supplied as an intravenous preparation and is administered by a qualified healthcare professional via infusion according to the protocol defined by the treating physician.

Serious risks have not been fully characterized, but potential concerns include severe hypersensitivity reactions such as anaphylaxis and possible organ toxicity. Ongoing monitoring during infusion is recommended.

Patients with a known hypersensitivity to any component of the formulation should avoid Illuccix. Until more safety data are available, clinicians should exercise caution in pregnant or breastfeeding individuals and those with significant organ impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Gozetotide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT